Sequential Dosing of Rituximab and IVIg for Desensitization of Highly-HLA Sensitized (HS) Patients Awaiting HLAi Kidney Transplantation.

被引：0
|
作者：
Vo, A. A. [1 ]
Huang, E. [1 ]
Williamsons, S. [1 ]
Myers, C. [1 ]
Peng, A. [1 ]
Najjar, R. [1 ]
Sethi, S. [1 ]
Lim, K. [1 ]
Ammerman, N. [1 ]
Gordan, S. C. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Kidney Transplant, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2019年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B183
引用
收藏
页码：812 / 813
页数：2
相关论文
共 50 条
  • [21] IMPROVING DECEASED DONOR TRANSPLANTATION FOR HIGHLY-HLA SENSITIZED PATIENTS
    Jordan, S. C.
    Reinsmoen, N.
    Lai, C.
    Cao, K.
    Kahwaji, J. A.
    Peng, A. A.
    Villicana, R.
    Vo, A. A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 212 - 212
  • [22] Efficacy and Cost Analysis of Desensitization Using IVIG and Rituximab for Transplanting Broadly HLA-Sensitized (HS) Patients
    Vo, A. A.
    Kahwaji, J.
    Peng, A.
    Villicana, R.
    Jordan, S. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 91 - 91
  • [23] Initial Experience with the Bacterial Enzyme IdeS® (IgG Endopeptidase) for Desensitization of Highly-HLA Sensitized (HS) Patients.
    Jordan, S.
    Choi, J.
    Zhang, X.
    Haas, M.
    Peng, A.
    Kahwaji, J.
    Villicana, R.
    Vo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 796 - 797
  • [24] Use of a Desensitization Protocol in Highly Sensitized yet Immunocompromised Patients Awaiting Kidney Transplantation
    Guerra, Juan Francisco
    Cummings, Lee S.
    Hawksworth, Jason S.
    Desai, Chirag S.
    Flanagan, Eleisha
    Girlanda, Rafaelle
    Johnson, Lynt B.
    Melancon, Joseph K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 72 - 72
  • [25] A novel therapeutic approach to improve rates and outcomes of deceased donor (DD) transplants in Highly-HLA sensitized patients (HS) using IVIG plus Rituximab
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Lukovsky, Marina
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 353 - 353
  • [26] Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly Human Leukocyte Antigen-Sensitized Patients Awaiting Kidney Transplantation
    Rehman, Shehzad
    Meier-Kriesche, Herwig-Ulf
    Scornik, Juan
    TRANSPLANTATION, 2010, 90 (08) : 932 - 932
  • [27] Long term graft and patient outcomes in highly-HLA sensitized (HS) patients desensitized with high dose (HD) IVIG
    Peng, Alice
    Vo, Ashley
    Villicana, Rafael
    Lee, Richard
    Dafoe, Donald
    Reinsmoen, Nancy
    Skinner, Edwina
    Jordan, Stanley
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 352 - 352
  • [28] Incidence and Clinical Severity of Hypogammaglobulinemia (Hypo-IgG) in Highly-HLA Sensitized Patients (HS) Undergoing Desensitization (DES)
    Vo, A.
    Ge, S.
    Petrosyan, A.
    Toyoda, M.
    Choi, J.
    Kahwaji, J.
    Peng, A.
    Villicana, R.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [29] Daratumumab for Desensitization and Antibody Mediated Rejection Treatment in Highly-HLA Sensitized Patients
    Jordan, S.
    Vescio, R.
    Ammerman, N.
    Toyoda, M.
    Ge, S.
    Chu, M.
    Hou, J.
    Huang, E.
    Peng, A.
    Sethi, S.
    Najjar, R.
    Lim, K.
    Kobashigawa, J.
    Patel, J.
    Kransdorf, E.
    Vo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 843 - 844
  • [30] Interim Analysis of a Double-Blinded Placebo Controlled Trial of IVIG v. IVIG plus Rituximab for Desensitization of Highly-HLA Sensitized (PRA >80%) (HS) Deceased Donor (DD) Candidates
    Vo, A.
    Choi, J.
    Lukovsky, M.
    Toyoda, M.
    Ge, S.
    Kahwaji, J.
    Peng, A.
    Villicana, R.
    Najjar, R.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 76 - 77
12345